CLX
The Clorox Company
NYSE · Consumer Defensive · Household & Personal Products · US
$93.06
−1.30%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.7B | 6.7B | 7.1B | 7.1B | 7.4B |
| Cost of Revenue | 3.9B | 3.9B | 3.9B | 4.0B | 4.5B |
| Gross Profit | 2.8B | 2.8B | 3.2B | 3.0B | 2.9B |
| Operating Expenses | |||||
| R&D Expense | 116.0M | 116.0M | 121.0M | 126.0M | 138.0M |
| SG&A Expense | 1.1B | 1.1B | 1.9B | 2.2B | 1.9B |
| General & Admin Expense | 768.0M | 317.0M | 1.1B | 1.3B | 1.2B |
| Selling & Marketing Expense | 533.0M | 749.0M | 770.0M | 832.0M | 734.0M |
| Other Expenses | — | — | 21.0M | 29.0M | 30.0M |
| Total Operating Expenses | 1.2B | 1.2B | 2.0B | 2.3B | 2.1B |
| Cost and Expenses | 5.1B | 5.1B | 5.9B | 6.4B | 6.6B |
| Operating Income (EBIT) | 1.7B | 1.7B | 1.2B | 723.0M | 823.0M |
| Non-Operating | |||||
| Interest Income | 8.0M | 8.0M | 9.0M | 23.0M | 16.0M |
| Interest Expense | 130.0M | 130.0M | 88.0M | 90.0M | 90.0M |
| Net Interest Income | (122.0M) | (122.0M) | (79.0M) | (67.0M) | (74.0M) |
| Other Non-Op Income/Expense | (871.0M) | (871.0M) | (99.0M) | (325.0M) | (585.0M) |
| Non-Operating Income (excl Interest) | 741.0M | 741.0M | 11.0M | 235.0M | 495.0M |
| EBT (Pre-Tax Income) | 791.0M | 791.0M | 1.1B | 398.0M | 238.0M |
| Income Tax Expense | 190.0M | 190.0M | 254.0M | 106.0M | 77.0M |
| Bottom Line | |||||
| Net Income | 587.0M | 587.0M | 810.0M | 280.0M | 149.0M |
| Earnings from Cont. Ops | 601.0M | 601.0M | 824.0M | 292.0M | 161.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 587.0M | 587.0M | 810.0M | 280.0M | 149.0M |
| Per Share | |||||
| Basic EPS | $4.82 | $4.82 | $6.56 | $2.25 | $1.21 |
| Diluted EPS | $4.81 | $4.81 | $6.52 | $2.25 | $1.20 |
| Revenue Per Share | $55.18 | $55.18 | $57.51 | $57.12 | $59.79 |
| Shares | |||||
| Basic Shares Outstanding | 121.8M | 121.8M | 123.5M | 124.2M | 123.6M |
| Diluted Shares Outstanding | 122.1M | 122.1M | 124.3M | 124.8M | 124.2M |
| Profitability Metrics | |||||
| EBITDA | 921.0M | 921.0M | 1.4B | 723.0M | 564.0M |
| D&A | — | — | 219.0M | 235.0M | 236.0M |
| EBIT | 921.0M | 921.0M | 1.2B | 488.0M | 328.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026